Project Details
Description
A Phase I/II Randomized, Double-Blind, Placebo-Controlled,Single-Dose, Dose Escalation Study of KB001 in Cystic FibrosisPatients Infected with Pseudomonas aeruginosa
| Status | Finished |
|---|---|
| Effective start/end date | 11/14/07 → 12/31/09 |
Funding
- KaloBios Pharmaceuticals, Inc.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.